|
GB202101972D0
|
|
Forskolin inducible promoters
|
|
GB202101966D0
|
|
Gene regulation system
|
|
GB202101969D0
|
|
Hypoxia inducible promoters
|
|
GB202014320D0
|
|
Synthetic regulatory nucleic acid sequences
|
|
GB202013940D0
|
|
Regulatory nucleic acid sequences
|
|
GB202012192D0
|
|
Regulatory nucleic acid sequences
|
|
GB202005732D0
|
|
Regulatory nucleic acid sequences
|
|
GB202005475D0
|
|
Hypoxia-inducible promoters
|
|
GB202005473D0
|
|
Forskolin-inducible promoters
|
|
GB201919269D0
|
|
Regulatory nucleic acid sequences
|
|
GB201905220D0
|
|
Forskolin-inducible promoters
|
|
GB201905219D0
|
|
Hypoxia-enducible promoters
|
|
GB201900741D0
|
|
Liver-specifc inducible prometers and methods of use thereof
|
|
GB201818816D0
|
|
Regulatory nucleic acid sequences
|
|
GB201803240D0
|
|
Methods and compositions for enriching nucleic acids
|
|
GB201713545D0
|
|
Expression control using a regulatable intron
|
|
GB201615386D0
|
|
Synthetic nucleotide sequences
|
|
GB201515996D0
|
|
Synthetic nucleotide sequences
|
|
GB201508302D0
|
|
Method of screening synthetic promotors
|
|
GB201407885D0
|
|
Screening of synthetic promoters
|
